Nov 10 (Reuters) - Cabaletta Bio Inc CABA.O :
* CABALETTA BIO REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS
AND
PROVIDES BUSINESS UPDATE
* CABALETTA BIO - AS OF SEPTEMBER 30, 2022, CO HAD CASH,
CASH
EQUIVALENTS AND INVESTMENTS OF $85.9 MILLION, COMPARED TO $122.2
MILLION AS OF DECEMBER 31, 2021
* CABALETTA BIO - EXPECTS THAT CASH, CASH
EQUIVALENTS,INVESTMENTS
AS OF SEPTEMBER 30, 2022, WILL ENABLE IT TO FUND ITS OPERATING
PLAN THROUGH Q2 OF 2024
* QTRLY LOSS PER SHARE $0.39
* Q3 EARNINGS PER SHARE VIEW $-0.48 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX3ch3SK
Further company coverage: CABA.O
((Reuters.Briefs@thomsonreuters.com;))